Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

The Binding Problem after an eye movement.

Dowd EW, Golomb JD.

Atten Percept Psychophys. 2019 Jun 3. doi: 10.3758/s13414-019-01739-y. [Epub ahead of print]

PMID:
31161496
2.

Gamma Band Light Stimulation in Human Case Studies: Groundwork for Potential Alzheimer's Disease Treatment.

Jones M, McDermott B, Oliveira BL, O'Brien A, Coogan D, Lang M, Moriarty N, Dowd E, Quinlan L, Mc Ginley B, Dunne E, Newell D, Porter E, Elahi MA, O' Halloran M, Shahzad A.

J Alzheimers Dis. 2019 May 27. doi: 10.3233/JAD-190299. [Epub ahead of print]

PMID:
31156180
3.

Viral mimetic priming enhances α-synuclein-induced degeneration: Implications for Parkinson's disease.

Olsen LK, Cairns AG, Ådén J, Moriarty N, Cabre S, Alamilla VR, Almqvist F, Dowd E, McKernan DP.

Brain Behav Immun. 2019 Apr 25. pii: S0889-1591(18)30768-2. doi: 10.1016/j.bbi.2019.04.036. [Epub ahead of print]

PMID:
31029796
4.

Object-Feature Binding Survives Dynamic Shifts of Spatial Attention.

Dowd EW, Golomb JD.

Psychol Sci. 2019 Mar;30(3):343-361. doi: 10.1177/0956797618818481. Epub 2019 Jan 29.

PMID:
30694718
5.

Harnessing stem cells and biomaterials to promote neural repair.

Bruggeman KF, Moriarty N, Dowd E, Nisbet DR, Parish CL.

Br J Pharmacol. 2019 Feb;176(3):355-368. doi: 10.1111/bph.14545. Epub 2018 Dec 21. Review.

PMID:
30444942
6.

OSPREY 3.0: Open-source protein redesign for you, with powerful new features.

Hallen MA, Martin JW, Ojewole A, Jou JD, Lowegard AU, Frenkel MS, Gainza P, Nisonoff HM, Mukund A, Wang S, Holt GT, Zhou D, Dowd E, Donald BR.

J Comput Chem. 2018 Nov 15;39(30):2494-2507. doi: 10.1002/jcc.25522. Epub 2018 Oct 14.

7.

In memory of Tom Isaacs: The epitomical mover and shaker.

Isaacs L, Barker R, Dowd E.

Eur J Neurosci. 2019 Feb;49(3):303. doi: 10.1111/ejn.14205. Epub 2018 Oct 31. No abstract available.

PMID:
30326157
8.
9.

Brain repair for Parkinson's disease: is the answer in the matrix?

Moriarty N, Dowd E.

Neural Regen Res. 2018 Jul;13(7):1187-1188. doi: 10.4103/1673-5374.235027. No abstract available.

10.

Primary tissue for cellular brain repair in Parkinson's disease: Promise, problems and the potential of biomaterials.

Moriarty N, Parish CL, Dowd E.

Eur J Neurosci. 2019 Feb;49(4):472-486. doi: 10.1111/ejn.14051. Epub 2018 Jul 10. Review.

PMID:
29923311
11.

Negative-Mass Instability of the Spin and Motion of an Atomic Gas Driven by Optical Cavity Backaction.

Kohler J, Gerber JA, Dowd E, Stamper-Kurn DM.

Phys Rev Lett. 2018 Jan 5;120(1):013601. doi: 10.1103/PhysRevLett.120.013601.

PMID:
29350956
13.

Time-course of striatal Toll-like receptor expression in neurotoxic, environmental and inflammatory rat models of Parkinson's disease.

McCabe K, Concannon RM, McKernan DP, Dowd E.

J Neuroimmunol. 2017 Sep 15;310:103-106. doi: 10.1016/j.jneuroim.2017.07.007. Epub 2017 Jul 13.

PMID:
28778432
14.

Neural Representation of Working Memory Content Is Modulated by Visual Attentional Demand.

Kiyonaga A, Dowd EW, Egner T.

J Cogn Neurosci. 2017 Dec;29(12):2011-2024. doi: 10.1162/jocn_a_01174. Epub 2017 Aug 4.

15.

Decoding working memory content from attentional biases.

Dowd EW, Pearson JM, Egner T.

Psychon Bull Rev. 2017 Aug;24(4):1252-1260. doi: 10.3758/s13423-016-1204-5.

16.

Trigeminal Receptor Study of High-Intensity Cooling Agents.

Johnson S, Tian M, Sheldon G, Dowd E.

J Agric Food Chem. 2018 Mar 14;66(10):2319-2323. doi: 10.1021/acs.jafc.6b04838. Epub 2017 Jan 11.

PMID:
28042937
17.

Central CB2 receptors in inflammation-driven neurodegeneration: dysregulation and therapeutic potential.

Concannon RM, Dowd E.

Neural Regen Res. 2016 Sep;11(9):1409-1410. No abstract available.

18.

Probabilistic Reinforcement Learning in Patients With Schizophrenia: Relationships to Anhedonia and Avolition.

Dowd EC, Frank MJ, Collins A, Gold JM, Barch DM.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Sep;1(5):460-473.

19.

Polyhydroxyalkanoate/carbon nanotube nanocomposites: flexible electrically conducting elastomers for neural applications.

Vallejo-Giraldo C, Pugliese E, Larrañaga A, Fernandez-Yague MA, Britton JJ, Trotier A, Tadayyon G, Kelly A, Rago I, Sarasua JR, Dowd E, Quinlan LR, Pandit A, Biggs MJ.

Nanomedicine (Lond). 2016 Oct;11(19):2547-63. doi: 10.2217/nnm-2016-0075. Epub 2016 Sep 13.

PMID:
27618972
20.

Interaction between subclinical doses of the Parkinson's disease associated gene, α-synuclein, and the pesticide, rotenone, precipitates motor dysfunction and nigrostriatal neurodegeneration in rats.

Naughton C, O'Toole D, Kirik D, Dowd E.

Behav Brain Res. 2017 Jan 1;316:160-168. doi: 10.1016/j.bbr.2016.08.056. Epub 2016 Aug 29.

PMID:
27585560
21.

Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation-driven rat models of Parkinson's disease.

Concannon RM, Okine BN, Finn DP, Dowd E.

Exp Neurol. 2016 Sep;283(Pt A):204-12. doi: 10.1016/j.expneurol.2016.06.014. Epub 2016 Jun 15.

PMID:
27317300
22.

Targeting delivery in Parkinson's disease.

Newland B, Dunnett SB, Dowd E.

Drug Discov Today. 2016 Aug;21(8):1313-20. doi: 10.1016/j.drudis.2016.06.003. Epub 2016 Jun 14. Review.

PMID:
27312875
23.

Fear generalization gradients in visuospatial attention.

Dowd EW, Mitroff SR, LaBar KS.

Emotion. 2016 Oct;16(7):1011-8. doi: 10.1037/emo0000197. Epub 2016 May 23.

PMID:
27213724
24.

Resistance and the Wounded Self: Self-Protection in Service of the Ego.

Dowd ET.

Am J Clin Hypn. 2016 Jul;59(1):100-13. doi: 10.1080/00029157.2016.1163656. Review.

PMID:
27196013
25.

Differential pattern of motor impairments in neurotoxic, environmental and inflammation-driven rat models of Parkinson's disease.

Naughton C, Moriarty N, Feehan J, O'Toole D, Dowd E.

Behav Brain Res. 2016 Jan 1;296:451-458. doi: 10.1016/j.bbr.2015.09.025. Epub 2015 Sep 21.

PMID:
26393432
26.

Experimental superposition of orders of quantum gates.

Procopio LM, Moqanaki A, Araújo M, Costa F, Alonso Calafell I, Dowd EG, Hamel DR, Rozema LA, Brukner Č, Walther P.

Nat Commun. 2015 Aug 7;6:7913. doi: 10.1038/ncomms8913.

27.

GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.

Hoban DB, Howard L, Dowd E.

Neuroscience. 2015 Sep 10;303:402-11. doi: 10.1016/j.neuroscience.2015.07.014. Epub 2015 Jul 10.

PMID:
26166730
28.

Differential upregulation of the cannabinoid CB₂ receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease.

Concannon RM, Okine BN, Finn DP, Dowd E.

Exp Neurol. 2015 Jul;269:133-41. doi: 10.1016/j.expneurol.2015.04.007. Epub 2015 Apr 18.

PMID:
25895887
29.

Fibrin-based microsphere reservoirs for delivery of neurotrophic factors to the brain.

Samal J, Hoban DB, Naughton C, Concannon R, Dowd E, Pandit A.

Nanomedicine (Lond). 2015;10(5):765-83. doi: 10.2217/nnm.14.221.

PMID:
25816879
30.

Attentional guidance by working memory differs by paradigm: an individual-differences approach.

Dowd EW, Kiyonaga A, Egner T, Mitroff SR.

Atten Percept Psychophys. 2015 Apr;77(3):704-12. doi: 10.3758/s13414-015-0847-z.

PMID:
25737257
31.

Examining perceptual and conceptual set biases in multiple-target visual search.

Biggs AT, Adamo SH, Dowd EW, Mitroff SR.

Atten Percept Psychophys. 2015 Apr;77(3):844-55. doi: 10.3758/s13414-014-0822-0.

PMID:
25678271
32.

Donald Hugh Blocher (1928-2013).

Dowd ET.

Am Psychol. 2015 Jan;70(1):48. doi: 10.1037/a0036647.

PMID:
25581010
33.

What can 1 billion trials tell us about visual search?

Mitroff SR, Biggs AT, Adamo SH, Dowd EW, Winkle J, Clark K.

J Exp Psychol Hum Percept Perform. 2015 Feb;41(1):1-5. doi: 10.1037/xhp0000012. Epub 2014 Dec 8.

PMID:
25485661
34.

Untying a nanoscale knotted polymer structure to linear chains for efficient gene delivery in vitro and to the brain.

Newland B, Aied A, Pinoncely AV, Zheng Y, Zhao T, Zhang H, Niemeier R, Dowd E, Pandit A, Wang W.

Nanoscale. 2014 Jul 7;6(13):7526-33. doi: 10.1039/c3nr06737h.

PMID:
24886722
35.

Heat shock protein 70 reduces α-synuclein-induced predegenerative neuronal dystrophy in the α-synuclein viral gene transfer rat model of Parkinson's disease.

Moloney TC, Hyland R, O'Toole D, Paucard A, Kirik D, O'Doherty A, Gorman AM, Dowd E.

CNS Neurosci Ther. 2014 Jan;20(1):50-8. doi: 10.1111/cns.12200. Epub 2013 Nov 27.

PMID:
24279716
36.

Alterations in regional functional coherence within the sensory-motor network in amyotrophic lateral sclerosis.

Zhou F, Xu R, Dowd E, Zang Y, Gong H, Wang Z.

Neurosci Lett. 2014 Jan 13;558:192-6. doi: 10.1016/j.neulet.2013.11.022. Epub 2013 Nov 22.

PMID:
24275213
37.

The reduction in immunogenicity of neurotrophin overexpressing stem cells after intra-striatal transplantation by encapsulation in an in situ gelling collagen hydrogel.

Hoban DB, Newland B, Moloney TC, Howard L, Pandit A, Dowd E.

Biomaterials. 2013 Dec;34(37):9420-9. doi: 10.1016/j.biomaterials.2013.08.073. Epub 2013 Sep 17.

PMID:
24054846
38.

Attentional guidance by working memory overrides salience cues in visual search.

Dowd EW, Mitroff SR.

J Exp Psychol Hum Percept Perform. 2013 Dec;39(6):1786-96. doi: 10.1037/a0032548. Epub 2013 Apr 8.

PMID:
23565744
39.

Nocturnal bruxism and hypnotherapy: a case study.

Dowd ET.

Int J Clin Exp Hypn. 2013;61(2):205-18. doi: 10.1080/00207144.2013.753832.

PMID:
23427844
40.

GDNF gene delivery via a 2-(dimethylamino)ethyl methacrylate based cyclized knot polymer for neuronal cell applications.

Newland B, Abu-Rub M, Naughton M, Zheng Y, Pinoncely AV, Collin E, Dowd E, Wang W, Pandit A.

ACS Chem Neurosci. 2013 Apr 17;4(4):540-6. doi: 10.1021/cn4000023. Epub 2013 Feb 11.

41.

The behavioural and neuropathological impact of intranigral AAV-α-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats.

Mulcahy P, O'Doherty A, Paucard A, O'Brien T, Kirik D, Dowd E.

Behav Brain Res. 2013 Apr 15;243:6-15. doi: 10.1016/j.bbr.2012.12.051. Epub 2013 Jan 4.

PMID:
23295396
42.

The neurotoxicity of gene vectors and its amelioration by packaging with collagen hollow spheres.

Newland B, Moloney TC, Fontana G, Browne S, Abu-Rub MT, Dowd E, Pandit AS.

Biomaterials. 2013 Mar;34(8):2130-41. doi: 10.1016/j.biomaterials.2012.11.049. Epub 2012 Dec 13.

PMID:
23245921
43.

Nigral grafts in animal models of Parkinson's disease. Is recovery beyond motor function possible?

Lelos MJ, Dowd E, Dunnett SB.

Prog Brain Res. 2012;200:113-42. doi: 10.1016/B978-0-444-59575-1.00006-5.

PMID:
23195417
44.

Guidelines for cognitive behavioral training within doctoral psychology programs in the United States: report of the Inter-organizational Task Force on Cognitive and Behavioral Psychology Doctoral Education.

Klepac RK, Ronan GF, Andrasik F, Arnold KD, Belar CD, Berry SL, Christofff KA, Craighead LW, Dougher MJ, Dowd ET, Herbert JD, McFarr LM, Rizvi SL, Sauer EM, Strauman TJ; Inter-organizational Task Force on Cognitive and Behavioral Psychology Doctoral Education.

Behav Ther. 2012 Dec;43(4):687-97. doi: 10.1016/j.beth.2012.05.002. Epub 2012 May 12.

45.

Further characterisation of the LPS model of Parkinson's disease: a comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat.

Hoban DB, Connaughton E, Connaughton C, Hogan G, Thornton C, Mulcahy P, Moloney TC, Dowd E.

Brain Behav Immun. 2013 Jan;27(1):91-100. doi: 10.1016/j.bbi.2012.10.001. Epub 2012 Oct 6.

PMID:
23044176
46.

Pavlovian reward prediction and receipt in schizophrenia: relationship to anhedonia.

Dowd EC, Barch DM.

PLoS One. 2012;7(5):e35622. doi: 10.1371/journal.pone.0035622. Epub 2012 May 4.

47.

Kinetics of thermally induced heat shock protein 27 and 70 expression by bone marrow-derived mesenchymal stem cells.

Moloney TC, Hoban DB, Barry FP, Howard L, Dowd E.

Protein Sci. 2012 Jun;21(6):904-9. doi: 10.1002/pro.2077. Epub 2012 May 8.

48.

Development and characterisation of a novel rat model of Parkinson's disease induced by sequential intranigral administration of AAV-α-synuclein and the pesticide, rotenone.

Mulcahy P, O'Doherty A, Paucard A, O'Brien T, Kirik D, Dowd E.

Neuroscience. 2012 Feb 17;203:170-9. doi: 10.1016/j.neuroscience.2011.12.011. Epub 2011 Dec 13.

PMID:
22198020
49.

Characterisation of a novel model of Parkinson's disease by intra-striatal infusion of the pesticide rotenone.

Mulcahy P, Walsh S, Paucard A, Rea K, Dowd E.

Neuroscience. 2011 May 5;181:234-42. doi: 10.1016/j.neuroscience.2011.01.038. Epub 2011 Jan 26.

PMID:
21277943
50.

Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat.

Walsh S, Finn DP, Dowd E.

Neuroscience. 2011 Feb 23;175:251-61. doi: 10.1016/j.neuroscience.2010.12.005. Epub 2010 Dec 9.

PMID:
21145947

Supplemental Content

Support Center